The 5-aminosalicylic acid antineoplastic effect in the intestine is mediated by PPARγ.
about
A Systems Pharmacology Approach to Determine Active Compounds and Action Mechanisms of Xipayi KuiJie'an enema for Treatment of Ulcerative colitis.PAK1 modulates a PPARγ/NF-κB cascade in intestinal inflammation.Integrative Network-based Analysis of Colonic Detoxification Gene Expression in Ulcerative Colitis According to Smoking Status.Interactions Between Inflammatory Bowel Disease Drugs and Chemotherapy.Chemopreventive effects of 5-aminosalicylic acid on inflammatory bowel disease-associated colorectal cancer and dysplasia: a systematic review with meta-analysis.
P2860
The 5-aminosalicylic acid antineoplastic effect in the intestine is mediated by PPARγ.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The 5-aminosalicylic acid antineoplastic effect in the intestine is mediated by PPARγ.
@en
The 5-aminosalicylic acid antineoplastic effect in the intestine is mediated by PPARγ.
@nl
type
label
The 5-aminosalicylic acid antineoplastic effect in the intestine is mediated by PPARγ.
@en
The 5-aminosalicylic acid antineoplastic effect in the intestine is mediated by PPARγ.
@nl
prefLabel
The 5-aminosalicylic acid antineoplastic effect in the intestine is mediated by PPARγ.
@en
The 5-aminosalicylic acid antineoplastic effect in the intestine is mediated by PPARγ.
@nl
P2093
P2860
P50
P356
P1433
P1476
The 5-aminosalicylic acid antineoplastic effect in the intestine is mediated by PPARγ.
@en
P2093
Audrey Langlois
Caroline Dubuquoy
Christel Rousseaux
David Buob
Denis Chatelain
Mathurin Fumery
Noura El-Jamal
Olivier Romano
P2860
P304
P356
10.1093/CARCIN/BGT245
P407
P577
2013-07-10T00:00:00Z